Category Healthtech
Current Stage Series B
Investment Date Sep 2021
Why We Invested

Annually, about 10% of hospitalizations and 15% of in-patient hospital procedures are attributed to the treatment of digestive diseases. Despite the high cost and high prevalence rate, access to high-quality gastrointestinal (GI) care is still a challenge for more than 70 million people in the US and driving more than $135 billion in annual healthcare costs. In a prospective clinical trial conducted in partnership with a national health plan, Oshi Health’s virtual multidisciplinary GI care model demonstrated statistically significant reductions in healthcare costs after six months, compared to propensity-matched controls. We are excited to support Oshi Health in its quest to democratize its groundbreaking, life-changing GI care.

About Oshi Health

Democratizing access to high value digestive care that’s proven to improve outcomes and significantly reduce healthcare costs. Oshi’s virtual-first care model provides diagnosis and multidisciplinary care for all GI conditions, empowering people to gain lasting control of their symptoms and improve their quality of life.

Digital health innovations are having a profound impact on the healthcare industry. At Oshi, we’re scaling access to multidisciplinary care that has not previously been properly supported or incentivized by traditional fee-for-service reimbursement. We are driving systemic change by working with health plan and employer partners to understand the structural and incentive gaps in digestive care, and forge contracts aligned to improving outcomes at lower cost.

Oshi Health Leadership